Recreational Injuries in Washington State National Parks
Background.-Some of the most popular and heavily used wilderness areas in the United States are the National Parks. Despite continued growth in popularity of these parks, there remain little data on the type and rate of injuries that are incurred by people participating in wilderness recreation.
Objective.-The objective of this study was to identify the number and type of recreational injuries sustained by the population of visitors to Mount Rainier National Park (MRNP) and Olympic National Park (ONP) in Washington State.
Methods.-This study was a retrospective review of case incident reports obtained by rangers in MRNP and ONP between 1997 and 2001. Data collected included victim age, gender, date of injury, activity pre-injury, type of injury, and mechanism of injury.
Results.-There were 535 cases of recreational wilderness injuries (including deaths) identified in these 2 parks, yielding an injury rate of 47.2 per million visitors in MRNP and 12.7 per million visits to ONP (22.4 injuries per million visits combined). The mean age of injury victims was 34. Males were more likely to suffer injury than females (59% vs 41%). The most common pre-injury activities included hiking (55%), winter sports (14.8%), and mountaineering (12%), and the most common type of injury included sprains, strains, and soft tissue injuries (26%); fracture/dislocations (26%); and lacerations (12%). Most injuries occurred during the summer months and between noon and 6:00 PM with 90% occurring during daylight hours. There were 1.4 deaths per million visits to MRNP and 0.5 deaths per million visits to ONP. The mean age of victims who died was 42, and no death occurred below the age of 19. Of 19 deaths in the 2 national parks during the 5-year period, 18 were accidental and 1 was a suicide. Of the 18 accidental deaths, 17 occurred among males. Mechanism of death included falls (37%), medical (21%), drowning (5%), and suicide (5%). Activities at the time of death included hiking (58%), mountaineering (26%), canoeing (5%), skiing (5%), and snowboarding (5%).
Conclusions.-In this study of 2 northwest National Parks, the most common type of injury was soft tissue injury; the most common cause of injury was a fall; and injuries occurred most commonly during hiking, during daylight hours, and in the summer. Individuals sustaining an injury resulting in death were significantly more likely to be male. Recreational injuries (both minor and serious) were more common in MRNP than in ONP. Knowledge of the types and causes of injuries and activities during which these injuries occur in National Parks can assist in determining the resources needed to help provide a safer environment for the increasing numbers of visitors to these parks. This information could be used to aid development of injury prevention strategies in the National Parks, guide training of rangers, guide education of people who recreate in the wilderness, and aid in the preparation of first aid kits. Background.-Intravenous crotaline Fab antivenom (FAB) is the current standard of care for the treatment of rattlesnake envenomation. Due to its high potency, low frequency of allergic reactions, and small molecular size, this antivenom may be well suited to local injection and venom neutralization at the envenomation site.
Methods.-We tested the effects of local, subcutaneous antivenom injection on limb swelling in a porcine model. Each animal was anesthetized, intubated, and maintained on mechanical ventilation. Crotalus atrox venom was then injected subcutaneously at the hock of the right hind leg. Animals were randomized to subcutaneous antivenom (SQ), intravenous antivenom (IV), or control arms. Interventions were made 2 minutes after venom injection. SQ animals received 2 vials of Fab subcutaneously at the envenomation site and 2 vials intravenously. IV animals received 4 vials of Fab intravenously. Limb circumference was measured hourly for 8 hours. Limb volumes were measured at 4 and 8 hours by water displacement.
Results.-Twenty-six animals were randomized to 3 treatment groups. The SQ and IV groups included 9 animals each. There were 8 controls. In the SQ group, 2 animals died suddenly within minutes of Fab injection. There were no deaths in the IV or control arms. Neither limb circumferences nor volumes were different between control and either treatment arms.
Conclusion.-Treatment of rattlesnake envenomation with SQ antivenom injection was associated with mortality not seen in other treatment groups. Neither SQ nor IV antivenom therapy was associated with less limb edema when compared to control. There is emerging evidence that the pattern of hypoxia is a critical factor in determining physiologic response, with intermittent hypoxia (IH) being a more potent stimulus than continuous hypoxia (CH).
Aims.-1. Compare cardiovascular (C-V) effects of IH vs CH (SpO 2 80%-90%). 2. Compare the effect of IH and CH on circulating and exhaled biomarkers. 3. Explore the relationship between the C-V impact of IH/CH and biological markers.
Design and Methods.-Within-subjects repeated measures design with subjects (18-45 year old healthy male volunteers) participating in 3 blocks: 1) control session (60 minutes of normoxia); 2) 3 consecutive days of IH (six 10 minute exposures to hypoxia with SpO 2 ϭ 80%-90%, and 10 minutes of normoxia between each hypoxia exposure); and 3) 3 consecutive days of CH (60 continuous minutes of SpO 2 ϭ 80%-90%). Systolic, diastolic, and mean blood pressure, heart rate, SpO 2 , and end tidal CO 2 were monitored and recorded. Exhaled nitric oxide (NO), carbon monoxide (CO), and serum nitrite levels were measured pre-and posthypoxia exposure. Data were analyzed using a 2 ϫ 3 ϫ 2 ANOVA.
Results.-Results are reported for the 5 subjects who have completed data collection to date. Heart rate (P ϭ .016), systolic blood pressure (P ϭ .034), and exhaled end tidal NO (P ϭ .013) were higher posthypoxia (regardless of IH/CH or day 1, 2, and 3). During IH, serum nitrite levels of 4 subjects were significantly higher (P ϭ .001) across days 1 to 3, and there was a significant interaction (P ϭ .007) posthypoxia exposure across days 1 to 3. This preliminary analysis suggests that short-term IH and CH episodes in normal males produces elevated SBP, HR, and exhaled NO postexposure. Analysis of serum nitrite levels from 4 subjects across days 1, 2, and 3 during IH may provide evidence of regulation of gene expression. 
Predictors of Lower Extremity Injury Among Climbers: A Cross-Sectional Investigation
Objective.-The purpose of the investigation was to determine characteristics of climbers that are predictive of foot and ankle injury.
Methods.-Climbing injury questionnaires were sent to 3500 randomly selected members of the American Alpine Club. Membership in this organization is limited to those with 2 or more years of climbing experience and as such comprises a nationwide group of experienced climbers. Six hundred three climbers responded by returning completed questionnaires. The data were compiled and a multivariable logistic regression analysis (SAS Version 8.02) was performed to identify predictors of injury. Strength of association was quantified using odds ratios. Serious injury was defined as frostbite or an ankle sprain or fracture sustained while climbing or approaching a climb. Minor injuries were defined as toenail pain and discoloration and foot pain and numbness not associated with serious injury.
Results.-When considering serious injury, there was a 15% increase in risk associated with a 1-point increase in climbing ability based on the Yosemite decimal system (P ϭ .02). There was also a 4% increase in risk of serious injury for 1-year increase in number of years climbing (P Ͻ .001). Adjusted for years of climbing, there was a 40% decrease in risk of any injury for a 10-year increase in age of climber (P Ͻ .001). Traditional climbers were more likely to sustain serious injuries (P Ͻ .001 compared to all other climbers). Relative to this group, sport climbers were the least likely to sustain serious injury (odds ratio adjusted for years of climbing of 0.48, P ϭ .02) followed by mountaineers (odds ratio 0.57, P Ͻ .01). Big-wall climbers and boulderers did not have significantly different injury rates.
Conclusion.-Advanced climbing ability, younger age, and traditional climbing are independently associated with increased risk of sustaining serious injury of the lower extremity while climbing.
The Introduction.-High altitude pulmonary edema (HAPE) is a potentially fatal altitude illness associated with elevated pulmonary artery pressures, occurring unpredictably in approximately 0.01% to 15% of individuals ascending above 10 000 feet. We hypothesized that the phosphodiesterase type 5 (PDE5) inhibitor, sildenafil, would be effective at reducing the magnitude of pulmonary artery hypertension associated with hypobaric hypoxia.
Methods.-Eleven healthy nonacclimatized subjects were investigated using Doppler-echocardiography at 2062 m (6762 feet) and then after rapid (3 hours) passive ascent to the summit at 4343 m (14 250 feet). Baseline systolic pulmonary artery pressures (sPpa) were determined at 2062 m and immediately prior to sildenafil administration on summit days 1 (SD1) and 2 (SD2). sPpa determinations were made 60 to 90 minutes following a 25-mg dose of oral sildenafil on SD1 and after a 100-mg dose on SD2. Among-group comparisons were performed using repeated measures analysis of variance with the Student-Newman-Keuls test for multiple comparisons. Data are reported as mean (Ϯ SD) and P Ͻ .05 was accepted as significant.
Results.-Adequate tricuspid jet envelopes were obtained on all 11 subjects at 4343 m. Arterial oxygen saturation (SpO 2 ) was 96.5 (Ϯ2.01) % at MWTC, 78.9 (Ϯ3.88) % on SD1, and 81.9 (Ϯ5.78) % on SD2 (P Ͻ .05). sPpa, estimated from the tricuspid regurgitation, increased from 19.9 (Ϯ1.83) mm Hg at MWTC to 38.2 (Ϯ9.59) mm Hg on SD1, and to 38.1 (Ϯ9.68) mm Hg on SD2 (P Ͻ .05). Oral sildenafil (25 mg) decreased sPpa to 29.1 (Ϯ8.42) mm Hg (P Ͻ .05) on SD1, while the 100-mg dose decreased sPpa to 29.0 (Ϯ6.01) mm Hg (P Ͻ .05) on SD2. There were no significant differences in systemic blood pressure, heart rate, or SpO 2 before or after sildenafil challenge on SD1 and SD2. Of note, 2 subjects with sPpa Ͼ50 mm Hg had a 30.9% reduction in sPpa, improved SpO 2 , and symptomatic improvement after sildenafil dosing on SD2.
Conclusion.-Inhibition of PDE5 by sildenafil was well tolerated and decreased sPpa without causing systemic hypotension or tachycardia. There was no significant difference between the responses to 25 mg vs 100 mg of oral sildenafil. This pilot study demonstrates that low-dose sildenafil may be a promising therapy for reducing hypoxic pulmonary vasoconstriction associated with exposure to high altitudes.
